New therapy may offer protection to severe peanut allergy sufferers

When:
Monday, March 10, noon, Eastern Time.

Who:
Donald Y. M. Leung, MD, FAAAAI, National Jewish Medical and Research Center, Denver
Hugh A. Sampson, MD, FAAAAI, Mt. Sinai School of Medicine
Anne Munoz-Furlong, Founder/CEO, The Food Allergy & Anaphylaxis Network

Where:
Adams Mark Hotel, Plaza Court 1
1550 Court Place
Denver, Colorado

Why:
Severe peanut allergy affects nearly 1.5 million people and is responsible for 50-100 deaths per year in the United States. Anaphylactic reactions to peanut can occur at any age and the only current treatment is peanut avoidance or rescue from epinephrine. However, only a small number of people carry epinephrine and even timely injection may not prevent death. The study's findings presented in the press conference may offer protection from most unintended ingestions.

For more information:
Contact John Gardner, Media Relations Coordinator, at 414/272-6071 or jgardner@aaaai.org.

EDITOR'S NOTE: the 60th Anniversary Meeting of the American Academy of Allergy, Asthma and Immunology will bring together more than 7,000 allergist/immunologists, allied health professionals and researchers from around the world. Members of the media may register without charge for the Annual Meeting. A press room with interview space, computers, modem lines, telephone and facsimile services will be available on-site for press conference representatives covering the meeting. For more information, contact John Gardner (jgardner@aaaai.org), ph. 414/272-6071; fax 414/272-6070. Visit the 60th Anniversary Meeting Online Newsroom at www.aaaai.org.